Patent Application
20070054400
The present invention relates to plants, preferably transgenic plants, such as (transgenic) wheat or maize, comprising a modified low molecular weight glutenin. It also concerns using seed and products thereof which are derived from those plants in the preparation of food and/or feed which is primarily gliadin-free and therefore beneficial for feeding patients suffering from among others coeliac disease and/or other forms of gluten intolerance.
Coeliac disease is a condition in which the lining of the small intestine is damaged by gluten, a mixture of different storage proteins found in the starchy endosperm of wheat and rye grains as well as in closely related species. The gluten matrix consists of approximately equal mixtures of gliadin and glutenin proteins. Coeliac disease is primarily caused by the gliadin proteins. Specifically, in this disease the villi of the small intestine are destroyed and the lining becomes flattened, seriously impairing nutrient absorption. Typical symptoms are weight loss, foul-smelling diarrhoe, vomiting, abdominal pain and swelling of the legs. The only cure currently available is a life-long gluten-free diet strictly avoiding all food and pharmaceutical compositions containing wheat, rye and barley.
Further, a number of humans suffer from general intolerance to glutens. The range of intolerance varies greatly although there are no clear clinical symptoms as in coeliac disease. Many humans therefore benefit from reducing the uptake of gluten.
When wheat flour is mixed with water the gluten proteins develop a unique, viscoelastic structure which enables the preparation of a large number of food products. Flour mixed with a small amount of water develops a dough, from which leavened bread, unleavened bread (for example nan, chapattis), biscuits, cookies, and cakes are made in various parts of the world. When a larger amount of water is added to flour, batters are formed and these are used to make wafers, pancakes and other products. Doughs made from durum wheat are used to make cous cous and pasta products: spaghetti, macaroni and the like. In all of these products the gluten matrix traps gas formed during cooking, which allows the developing product to rise/extend through viscous flow and yet maintains the structure (of the product) by developing elastic restraint.
The gliadin proteins comprise a complex mixture of monomeric polypeptides ranging from about 30,000 to 70,000 in molecular weight. The gliadins are often classified into distinct groups, the α/β-, γ- and ω-gliadins.
In contrast, the glutenin proteins have a molecular weight of up to several millions and are among the largest natural polymers known today. They are formed from polypeptide subunits linked via disulphide bonds. The majority of the monomers have a molecular weight which is similar to the gliadins and are called low-molecular-weight (LMW) subunits. The remainder are larger and are referred to as high-molecular-weight (HMW) glutenin subunits. Gliadins and glutenins are conveniently separated by extracting flour with aqueous alcohols, as the gliadins are soluble and the glutenins insoluble under these conditions.
The gliadins impart viscous flow or extensibility to a dough whereas glutenins impart both elasticity and extensibility. The large glutenin molecules contribute more to elasticity and less to extensibility, whereas the smaller glutenin molecules have the reverse effect. Thus the mean molecular weight distribution of the glutenin monomers as well as the ratio of glutenin to gliadin governs the visco-elasticity of the dough. The different foodstuffs of wheat described above require different visco-elastic properties. For example bread requires a balance of extensibility (to allow the dough to rise) and elasticity (to hold the dough volume before it sets in the oven) whereas biscuits require maximum extension (to enable thin dough sheets to be produced) and minimal elasticity (which would cause biscuit shrinkage prior to baking).
The gluten proteins of wheat are also consumed in a number of other products. Isolated gliadins have film-forming properties and are used as a surface layer or coating on confectionery to inhibit stickiness. Gliadins are further applied as a surface coating to pharmaceutical tablets for the same reason, or to inhibit the taste of unpleasant flavours during consumption of the tablet. Individuals with severe forms of coeliac disease will already be at risk from consumption of these products.
The structures of α/β-gliadins, γ-gliadins and LMW glutenin subunits are closely related and amino acid sequences are homologous in two of five sequence domains (see
Nearly all LMW genes have 5 domains. The first domain containing one cystein residue is missing only in two sequences analyzed so far. Domain II, so-called repetitive domain is highly variable among the different members of LMW subfamilies. Domain III is a highly conserved domain containing 5 cystein residues found in all LMW genes. Domain IV is glutamine rich, but variable between the different subfamilies. Domain V is a conserved sequence terminating the LMWs and containing the sixth and final cystein residue. The derived amino acid sequences would result in polypeptides ranging from 33.4 to 39.5 KDa.
α- and γ-gliadins and LMW glutenins contain 6 or 8 cysteine residues that form 3 or 4 homologous intramolecular disulfide bonds. The location of these cysteine residues in the amino acid sequence is conserved among most LMW glutenin proteins. Two of the cysteine residues present in LMW glutenins form intermolecular disulfide bonds with the cysteine residues of other glutenin proteins. These 2 cysteine residues are thus responsible for the aggregative nature of LMW glutenin subunits. The structure of the storage proteins and the relevance of the cysteine residues for intermolecular crosslinking of glutenins has been analyzed in great detail in the art (Weegels and Hamer, J. Cereal Science, vol. 25 (1997), 155-163; Orsy et al., J. Biological Chemistry, vol. 276 (2001), 32322-32329; Shewry and Tatham, J. Cereal Science, vol. 25 (1997), 207-227; Lindsay et al., J. Cereal Science, vol. 31 (2000), 321-333; and Müller et al., J. Cereal Science, vol. 27 (1998), 109-116).
The use of genetic engineering methods for modifying or improving wheat gluten and wheat products has been suggested in the art. Vasil and Andersen for example suggested to modify wheat gluten by increasing the numbers of HMW-GS genes, to alter the number and position of cysteine residues, to change the physical characteristics of the gluten matrix, to change the composition and arrangement of the repeat motifs in the repetitive domain, to increase the proportion of glutenins in the large polymer fraction, to modify the polymer network, to introduce LMW-GSs with only one available cysteine for intermolecular bonds as polymer chain terminators and to modify the LMW-GSs to achieve modification of wheat quality (Trends Plant Sci., vol. 2 (1997), 292-297).
Modified glutenin genes, wherein sequences encoding a domain which confers the ability to incorporate into a gluten or bind a ligand or other macromolecule were introduced into the gene sequence, have further been reported in the art (WO00/02914).
However, so far no suggestions have been made for improving the gluten composition in such a manner that foodstuffs prepared thereof are less of a risk to patients with coeliac disease and/or other forms of gluten intolerance.
The present invention thus seeks to provide gliadin-free or gliadin-reduced foodstuff prepared from wheat, maize and/or flour derived thereof, beneficial for feeding patients suffering from coeliac disease and/or other forms of gluten intolerance, while maintaining the advantagous functional characteristics of conventional wheat, maize and/or flour containing for example wheat storage proteins.
The above mentioned problem is solved by the provision of a host cell more specifically a plant cell, preferably from wheat or maize, comprising a nucleic acid sequence as set forth in SEQ ID NO: 1 and/or homologous thereof encoding a modified glutenin polypeptide as for example set forth in SEQ ID NO. 2. Said host cells comprising a sequence as set forth in SEQ.ID.NO 1 encoding a modified glutenin polypeptide, wherein the sequences encoding one or more cysteine residues responsible for intermolecular crosslinking via disulfide bridges were deleted or sub-stituted by sequences encoding other amino acids without amending the reading frame of the coding sequence.
For sake of clarity if a cysteine residue is referred to as “a cysteine residue responsible for intermolecular crosslinking via disulfide bridges”, the polypeptide containing a respective cysteine residue will form crosslinked di-, oligo- or polymers with other glutenin polypeptides containing respective cysteine residues at appropriate conditions which will allow formation of disulfide bonds, such as under the conditions obtained by expression in plant cells. Since the domain structure and the crosslinking activity of the various cysteine residues in glutenin genes are well known in the art, one of ordinary skill in the art will have no problem whatsoever to identify the cysteine residues which have to be modified or deleted in any known or newly isolated glutenin gene to result in substantially the same functionality as the current SEQ ID NO. 1 viz. providing substantially gliadin-free foodstuff prepared from cereals such as wheat, maize and/or flour derived thereof, while maintaining the advantagous functional characteristics of conventional cereals.
Alignment of different types of LMW subunits show the distribution of cysteine residues in the amino acid sequences. The distribution of the cysteine residues involved in the formation of intermolecular disulfide bonds is conserved in LMW sequences and can be used for classification of the known LMW subunit sequences.
Numerous wild type genes encoding LMW glutenins are known in the art though (Cassidy et al., Theor. Appl. Genet., 1998, 96: 743-750). Specific reference with respect to the current invention is made to the highly conserved motifs between different LMW-glutelins as mentioned in Cassidy et. al. (1998).
The glutenin genes used in the present invention differ from known sulfur rich prolamines, such as wild-type gliadin genes. Comparing the glutenin genes used in the present invention with a natural gliadin gene for example shows low (below 50%, preferably below 30%) or no homology of the genes in the 5′-end nucleotide sequence of the gene, wherein the 5′-end nucleotide sequence covers at least 15, preferably at least 30 of the nucleotides found at the 5′-end of the coding region.
In a preferred embodiment of the present invention, the used glutenin gene sequence comprises a sequence having a homology of at least 75% to the sequence shown in SEQ ID NO: 1. Preferably the sequence homology is at least 85% or at least 95% to the sequence shown in SEQ ID NO: 1. Methods for determining sequence homology are well known in the art. According to a preferred embodiment of the present invention sequence homology is determined using the BLAST Software.
The present invention is further directed to a plant preferably a transgenic plant, more specifically a cereal plant such as wheat or maize, containing plant cells wherein SEQ ID. NO 1 is integrated in the genetic material of the cell.
The transgenic plant, wheat or maize, may for example express the polypeptide encoded by SEQ ID NO 1 and depicted as SEQ. ID NO 2 in the seed and thus provide a seed containing a gliadin substitute.
Specific advantages of the present invention are obtained if the expression of at least one of the endogenous gliadin genes in the genome of a transgenic wheat plant is reduced or inhibited.
Part of the invention is the provision of transgenic plants wherein for example the expression of all endogenous gliadin genes in the genome of the plant has been reduced or inhibited and which—at the same time-express the modified glutenin polypeptide which does not contain any cysteine residues responsible for intermolecular crosslinking. The storage proteins of the seed of respective transgenic plants thus no longer contain gliadin. For the purpose of preparing foodstuffs from the seed of respective transgenic plants the modified glutenin polypeptide as depicted in SEQ ID NO 2 serves as a gliadin substitute.
Furthermore within the scope of the present invention is a transgenic plant wherein the reduction or inhibition of earlier mentioned expression comprises a modification of the cis and/or transactivating regulatory sequences and/or comprises a modification of the coding sequence of a gliadin gene and/or wherein said expression is influenced by an RNA interfering sequence or by an anti sense gliadin sequence as such.
The modification of the genes or sequences mentioned above comprises either a deletion, substitution or addition of the appropriate nucleotide sequences known to a person skilled in the art how to comply herewith.
Seed and/or products derived thereof like whole grain, wet-milled grain, starch, other protein fractions or flour, of a transgenic plant as described above is also within the scope of the current invention.
Within the scope of the present invention is a method of preparing a transformed plant cell comprising several steps wherein a plant cell is transformed with a nucleic acid sequence as set forth in SEQ ID NO 1. Transformation of plant cells is preferably used to prepare transgenic plants. Transgenic plants may for example be prepared by regeneration of transformed plants from transformed plant cells. Numerous methods for transformation of plant cells and regeneration of full fertile plants are known in the art. Transformation of plant cells are known in the art and the method used largely depends on the plant cell type used. Reference is made to among others Agrobacterium transformation and shot gun or biolistic transformation methods.
The transgenic plant may further comprise a genetic alteration, which inhibits or reduces the expression of at least one endogenous gliadin gene. The genetic alteration may be introduced before, together with or after the transformation with the nucleic acid sequence as set forth in SEQ ID NO:1.
According to a preferred embodiment of the invention all genes encoding a gliadin polypeptide are inactivated in the plant genome. This method provides cereal plants, such as wheat or maize, having seed, wherein no natural gliadin polypeptides are expressed. At the same time the modified glutenin as set forth in SEQ ID NO 2, which does not contain any cysteine residue responsible for intermolecular crosslinking is expressed as a gliadin substitute.
A thus obtained stable transformed transgenic cereal plant can, after transformation, be crossed by conventional breeding with other cereal varieties whereby the genetic means for modified low molecular weight glutenin is ultimately introgressed in elite lines for bulk production of seed for further use in the preparation of food stuff. In addition, alternatively, a natural occuring cereal variety or a special selected variety, like a gliadin-null variety, can be used for breeding with the variety containing the desired trait obtained by the current invention.
The functionality of the cereals as used for several purposes depending on its final product can thus be restored in using those gliadin-null varieties with introgression of the trait containing the modified low molecular weight glutenin according to the invention.
In addition to restoring functionality to wheat that has been modified to reduce gliadin expression, the sequence SEQ ID. NO I may alternatively be expressed to varying levels in different genetic backgrounds as a tool to modulate extensibility. Such wheats have novel functionality and end use properties.
Specific advantages are obtained if seeds or other parts thereof derived from a transgenic plant are used for the preparation of foodstuff. If the transgenic plant is a cereal, one will obtain foodstuff having a significantly reduced gliadin concentration. The foodstuff may comprise dough, batters, pastries, cookies, pasta, waffers, bread and/or confectionery. Such foodstuff is better tolerated and may advantageously be consumed by patients with coeliac disease or general intolerance to wheat. The latter foodstuff has the advantagous properties of respective foodstuffs prepared from wheat or maize containing LMW glutenin subunit(s) and can be consumed by patients with coeliac disease with less or without side effects and thus addresses a long felt need, specifically in the treatment of patients with coeliac disease or general intolerance to gluten.
The GUS-reporter Gene Constructs
The uidA-reportergene construct p1.7γZGUS (Torrent et al. 1997) harbouring the maize 27 kDa γzein gene promoter was obtained from Dr. D. Ludevid (Institut Biologia Molecular Barcelona, Spain).
The construct pHMW4-GUS harbouring a High Molecular Weight glutenin gene promoter from Triticum aestivum cv. Florida in front of the uidA gene was obtained from Drs. S. Lütticke and S. Sprunck (Institut für Aligemeine Botanik, Universität Hamburg, Germany). It was cloned the following way: The High Molecular Weight glutenin promoter was amplified from genomic DNA of the wheat cv. Florida using the primers HMW1 (5′-CGAATTCGATCCTATATTAATTTTAGACAT-3′) and HMW3 (5′-GCTGCAGATATCTCGGTGGACTATCAGTGAATT-3′). The ends of the PCR fragment were blunted using Pfu DNA polymerase and ligated into the plasmid pCR-Script-Amp (Stratagene, La Jolla, USA) which was linearised with Srf I. From this construct the promoter was amplified with the primers M13 forward and HMW4 (5′-GGCCGCTCTAGCCGAATTCATCTCGGTGGACTA-3′). This PCR product was cut with EcoR I and ligated into pBluescript KS+ (Stratagene, La Jolla, USA), which was also linearised with EcoR I, yielding the construct HMW4/Eco. The promoter was isolated from HMW4/Eco as an EcoR I fragment, blunted with mung bean nuclease and ligated into the plasmid gusnos630 (pBluescript SK-harbouring the uidA-nos terminator fragment from the plasmid CalGUS (Callis et al. 1987)), which was cut with Nco I and blunted with mung bean nuclease. This resulted in the plasmid pHMW4-GUS.
In order to evaluate the strength of expression generated by the two endosperm specific promoters High Molecular Weight glutenin promoter and 27 kDa γ Zein promoter, thus finding which of these is more suitable for the high level expression of recombinant storage proteins in maize endosperm, maize was transformed with the respective uidA reporter gene constructs p1.7γZGUS and pHMW4-GUS respectively. Endosperm representing the T1 generation was analysed for the amount of β-glucuronidase activity. It was found that the expression driven by the HMW glutenin promoter is at least three times as much as the one driven by the γ Zein promoter (
Histochemical and Fluorometric Analysis of β-glucuronidase Activity
Histochemical and fluorometric analysis of β-glucuronidase activity was essentially performed as described by Jefferson et al. (1987). TO plants were pollinated with pollen from the inbred line A188. Twenty-eight dap, from each cob 20 kernels, representing the T1 generation were tested histochemically for GUS activity: After surface sterilisation the embryos were removed from the kernels, which then were cut in half. Subsequently one half of each kernel was subjected to the histochemical GUS assay. On an average eight kernels, which showed GUS activity in the endosperm and two kernels, which did not as a negative control, were used to quantify GUS activity fluorometrically: Protein extracts from the second halves of the respective kernels were used in the fluorometric assay, deploying a Fluoroscan II fluorimeter (Labsystems) with 4-methylumbiliferone as a standard according to the manufacturer's instructions.
Construction of LMW Glutenin a3 and LMW Glutenin a3Δ2C Expression Plasmids:
The expression constructs are based on the plasmid litmus38 (New England Biolabs, Beverly, Mass., USA). 589 bp from the 3′ UTR of the 27 kDa γZein Zc2 from maize (Reina et al., 1990: Sequence analysis of a genomic clone encoding a Zc2 protein from Zea mays W64 A. Nucl. Acids Res., 18, 6426) were amplified by PCR from the plasmid p2-16, which harbours the respective sequence from the imbred line A188.
The oligonucleotides γZT5′-BamHI (5′-GCTCGGATCCCCTAGGTACCTGAAGAAACTATGTGCTGTAGTATAGCC-3′) and γZT3′-Sfil (5′-GCTCTGTACAGGCCCTTAAGGCCGCTTCAAGTCTTTAACTAAGGGAGG-3′) were used for the PCR reaction.
The PCR product was ligated with T4 DNA ligase (Invitrogen GmbH, Karlsruhe, Germany) into litmus38 taking advantage of the BamHI and BsrGI restriction sites, yielding the plasmid pL-Zc2T (
718 bp from the region upstream of the start-ATG of a High Molecular Weight (HMW) glutenin gene from the German wheat cultivar Florida were introduced into pL-Zc2T in front of the γZein 3′ UTR: The promoter was amplified by PCR from the plasmid pHMW4-GUS using the oligonucleotides HMW—5′-SfiI (5′-GCTCGGGCCCGGCCATGGCGGCCGAATTCGATCCTATATTAATTTT-3′) and HMW—3′-NdeI (5′-CAGTGGATCCCATATGCTCGGTAGGACTATCAGTGAATT-3′) and ligated with T4 DNA ligase (Invitrogen GmbH, Karlsruhe, Germany) into pL-Zc2T taking advantage of the ApaI and BamHI restriction sites. This resulted in the plasmid pHMWz (
The cDNAs of the Low Molecular Weight (LMW) glutenin a3 and its modified version a3Δ2C were introduced in pHMWz between the HMW glutenin promoter and the γZein 3′ UTR: The two cDNAs were amplified by PCR from the plasmids pBluescript-LMWa3 and YpADH-LMWa3Δcys2 respectively using the oligonucleotides LMWa3—5′ (5′-AGATCCGTACATATGAAGACCTTCCTCGTCTTTGCC-3′) and LMWa3—3′ (5′-GCTATCTAGAT6CAGTAGGCACCAACTCGGCTGCC-3′) and then ligated with T4 DNA ligase (Invitrogen GmbH, Karlsruhe, Germany) into pHMWz using the NdeI and AvrII/XbaI restriction sites, taking advantage of the compatible overhangs of cleaved AvrII and XbaI sites. This resulted in the expression plasmids pHMW-a3z (
Production of Wheat Plants which Express a Modified LMW Gene from Triticum aestivum.
The biolistic transformation method is used for the production of wheat (Becker et al., Plant J. 5(2), 1994, 229-307). The vector pHMW-a3Δ2Cz and, for biolistic cotransformation, the vector pAct1-Fneo (Müller et al., Plant Science 114, (1996), 71-82) are used in identical molar ratios in the DNA particle precipitation batch. Scutelli from 14-day old, unripe zygotic embryos of wheat plants were used as target cells for transformation. Transformation was followed by in vitro culture on MS− medium (PCT/EP97/02793) containing 2 mg/l 2,4-D (=2,4-dichlorophenoxyacetic acid). Two weeks after transformation, subculture is effected on the same medium, to which 150 mg/l kanamycin sulphate is added. After a further two weeks, the developing calli are transplanted on to a regeneration medium (MS− medium with 0.1 mg/l 2,4-D and 150 mg/l Kanamycin). The developing shoots are transferred to semi-concentrated MS− medium without 2,4-D and kanamycin and are subsequently transferred into the ground. About 14 days after their establishment in the ground, the transgenic plants are identified by spraying twice with an aqueous solution containing 2.5 and 3.0% Kanamycin sulphate, 0.1% Tween20.
Production of Maize Plants which Express a Modified LMW Gene from Triticum aestivum
The biolistic transformation method is used for the production of maize (Brettschneider et al., 1997, Theor. Appl. Genet 94, 737-748). The vector pHMW-a3Δ2Cz and, for biolistic cotransformation, the vector pUbi2loxPAT (
The pat gene from S. viridochromo genes (Wohileben et al., Gene 70, (1988), 25-37) was isolated as a SalI fragment from the vector p35SPAT and introduced as a blunt end fragment into pUbi.2lox.nos digested with SmaI resulting in plasmid pUbi.2lox.pat (
The resulting construct pHMW-a3Δ2Cz (
1.0-1.4 mm long immature zygotic embryos were isolated and cultured on N6.1.100.25 (N6) nutrient medium (Songstad D. D., Petersen W. L., Armstrong C. L. (1992). Am. J. Bot. 79, 761-764). The modifications to the original protocol from Brettschneider et al. (1997) are:
a) Freshly isolated embryos were cultured for one day on N6 sucrose medium with an osmotic value of 700 mOsm. Next day, embryos are subcultured on normal N6.1.100.25 medium supplemented with 1 mg/l 2,4-D for 5-12 days before microprojectile bombardment.
b) The BASTA selection was started 14 days after bombardment when the calli were subcultured on N6.1.100.25 medium, supplemented with 1 mg/l 2,4-D and 1 mg/l PPT (Phosphinothricin), the active compound of the commercial herbicide Basta. During herbicide selection, all media were preparated without casamino acids
c) All media were solidified with Phytagel instead of Agarose.
Herbicide- and Antibiotic Application
All regenerants from the selection experiments as well as progeny were sprayed two to three times with an aqueous solution of BASTA containing 250-300 mg/l phosphinothricin, 0,1% Tween 20 (maize) or 2.5-3% kanamycin, 0.1% Tween 20 (wheat). Surviving plants were further grown to maturity in the glasshouse. Plants which were transgenic for the selectable marker genes were further characterised by Southern- and Western blot analysis and by HPLC for the presence and expression of the wheat seed storage proteins, especially for the integration and expression of the LMW and modified LMW genes.
Integration and Expression of the LMW and Modified LMW Genes in T0 Plants
Integration and expression of the LMW- and modified LMW genes in transgenic plants was detected by Southern-, Western blotting and by HPLC (Wieser et al. 1998). LMW and modified LMW protein was detected in the transgenic seed protein preparations 4 weeks after pollination with the aid of polyclonal antibodies.
Southern Blot Analysis
Total genomic DNA was isolated from leaf tissue with a rapid extraction protocol (Palotta et al. 2000). Uncut and restriction enzyme-digested genomic DNA (15 μg per lane) or 20 pg of restricted plasmid DNA (positive control) were separated in a 0.8% agarose gel, blotted onto a Hybond NX nylon membrane (Amersham, Braunschweig, Germany), and hybridized to 32P-labeled probes synthesized from DNA restriction fragments with the Deca Label DNA labeling Kit (MBI Fermentas, St. Leon-Rot, Germany). Non incorporated nucleotides were removed with Microspin columns HR S300 (Pharmacia, Erlangen, Germany), and hybridization was carried out as described (Sauter 1997). Blots were washed successively at 68° C. for 10 min in 2×SSC, 0.1%SDS; 0.5×SSC, 0.1% SDS and 0.2×SSC, 0.1% SDS.
Protein Extraction
For one-dimensional SDS-PAGE endosperm from seeds were ground using a mortar and pestle in 2×PBS (PBS=10 mM phosphate buffer, pH 7.4, 140 mM sodium chloride) (1 ml per 2 g FW). After centrifugation (20100×g, 15 min, 4° C.) the protein content in the supernatant was determined according to Bradford (1976). Depending on the protein concentration an equal volume of 2×SDS sample buffer (Laemmli, 1970) was added.
Electrophoresis
One-dimensional electrophoresis was performed according to Laemmli (1970). The gel concentration was between 6-12%. Either 13 or 3 μg of protein per lane were loaded onto minigels (8×10 cm) followed by Comassie or silver staining or for Western blot analysis, respectively. Western blotting was performed according to Albrecht et al. (1998).
Production of Progeny from Transgenic Maize Plants.
Progeny plants were produced from mature seeds in the glasshouse or by embryo rescue. Therefore, immature embryos were isolated from immature seeds 4 weeks after pollination.
Seeds were surface sterilized (1% sodium hypochloride, 0.5% Mucasol) for 20 min and washed three times with sterile distilled water. Embryos were excised from the seeds under aseptic conditions and placed with the scutellum in contact to solidified (0.4% agarose) MS-medium without phytohormons (Murashige and Skoog, 1962).
Dough Production for Micro-Baking Test
For micro-baking tests, 10 g maize flour, 0.2 g NaCl, 0.4 g glucose, 0.7 g fresh bakery yeast, and 2 ml of H2O were mixed for 2 min at 22° C. in the Farinograph. The dough was put in little pans coated with Teflon and allowed to stand for 40 min at 30° C. The baking time was 10 min at 240° C.
Preparation of Storage Protein Extracts from Maize Endosperm
Four week old embryos were isolated from the kernels and transferred under sterile conditions onto MS media. The remaining kernel was stripped of the pericarp and frozen in liquid nitrogen and stored away for further processing at −70° C. For the extraction of storage proteins, endosperms from which the respective seedling had been tested positive for the transgene by PCR were handled the following way: the endosperms were ground under liquid nitrogen. Then approximately one third of each sample was extracted two times with 0.5 mL 0.4 mol/L NaCl, 0.067 mol/L HKNaPO4, pH 7.6 for 10 min while stirring at room temperature. After each extraction the samples were centrifuged at 13000 rpm for 7 min at room temperature. The supernatants were discarded and the samples were then extracted two times with 0.5 mL 50% (v/v) 2-propanol, 2 mol/L urea, 0.05 mol/L Tris-HCl, pH 7.5, 1% (w/v) DTT for 20 min while stirring at 60° C. Here again the samples were centrifuged at 13000 rpm for 7 min at room temperature. The supernatants of each sample were collected and then dried in a centrifuge concentrator and resuspended in 100 μl SDS-PAGE sample buffer (Laemmli 1970).
SDS-Polyacrylamide Gel Electrophoresis
Five μl of the samples were loaded onto a 12% SDS-PAGE-mini gel, which was prepared according to Laemmli (1970). After the gel run the gel was stained in 50% (v/v) methanol, 10% (v/v) acetic acid and 0.25% (w/v) Coomassie Brilliant Blue R-250 for 1 hour. The gel was destained in 5% (v/v) methanol, 7.5% (v/v) acetic acid for several hours.
Results
By ‘biolistically’ transforming in mature embryos of the maize hybrid A188xH99 with expression constructs for the Low Molecular Weight (LMW) glutenin a3 (pHMW-a3z) or its modified variant (pHMW-a3Δ2Cz), both under a High Molecular Weight (HMW) glutenin subunit promoter from wheat cultivar ‘Florida’, it was shown to generate transgenic maize lines harbouring the respective full-length expression cassettes in their genomes. This was shown by genomic Southern blot analysis: The full length expression cassettes were cut from genomic DNA, using the Sfi I restriction endonuclease, and probing the respective blots with a labelled HMW promoter sequence revealed the presence of full length fragments of the same size as in the respective plasmid controls (
| Number | Date | Country | Kind |
|---|---|---|---|
| 03004633.8 | Mar 2003 | EP | regional |
| Filing Document | Filing Date | Country | Kind | 371c Date |
|---|---|---|---|---|
| PCT/EP04/02079 | 3/2/2004 | WO | 12/27/2005 |
